Although extensive analyses have indicated the potential of urine HE4 as a novel diagnostic marker for ovarian cancer, the previous studies have been limited by relatively small patient populations, and no previously published meta-analyses have addressed this research question. This evidence concerns the gene WFDC2 and ovarian carcinoma.